The list for the next round of medicines that will ... reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process.

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best ...

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...

GlaxoSmithKline has joined the ranks of drugmakers trying to develop new drugs for non-alcoholic steatohepatitis (NASH) – a condition with no approved therapies and a lengthy list of failed drug ...

GSK’s blood cancer drug Blenrep won regulatory approval in the U.K., marking the medicine’s return to the market after it was ...

British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed. A pension fund has filed a class action ...

The deal kicks off with GSK paying South Korea-based ABL £38.5 million (about $49.1 million) up front. The drug delivery approach of ABL is based on Grabody, a platform technology that develops ...

The company's innovative new product lineup and expansive list of patent-protected drugs create a wide economic moat, in our opinion. The magnitude of GSK's reach is evidenced by a product ...

The increased usage of specialty drugs is contributing to the continued ... includes pharmaceutical products. GSK plc (NYSE:GSK) tops our list for being one of the most undervalued stocks.

Per GSK, the drug targets a different part of the bacteria than most existing antibiotics, making it effective against resistant strains. Additionally, the risk of bacterial resistance is low ...

At GlaxoSmithKline, we never lose sight of the ... In particular, a platform trial design allows efficient evaluation of a drug in combination with agents with different mechanisms of action ...